Literature DB >> 23747506

Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells.

Nadège Grabowski1, Hervé Hillaireau, Juliette Vergnaud, Letícia Aragão Santiago, Saadia Kerdine-Romer, Marc Pallardy, Nicolas Tsapis, Elias Fattal.   

Abstract

In vitro cytotoxicity and inflammatory response following exposure to nanoparticles (NPs) made of poly(lactide-co-glycolide) (PLGA) have been investigated on A549 human lung epithelial cells. Three different PLGA NPs (230 nm) were obtained using different stabilizers (polyvinyl alcohol, chitosan, or Pluronic(®) F68) to form respectively neutral, positively or negatively charged NPs. Polystyrene NPs were used as polymeric but non-biodegradable NPs, and titanium dioxide (anatase and rutile) as inorganic NPs, for comparison. Cytotoxicity was evaluated through mitochondrial activity as well as membrane integrity (lactate dehydrogenase release, trypan blue exclusion, propidium iodide staining). The cytotoxicity of PLGA-based and polystyrene NPs was lower or equivalent to the one observed after exposure to titanium dioxide NPs. The inflammatory response, evaluated through the release of the IL-6, IL-8, MCP-1, TNF-α cytokines, was low for all NPs. However, some differences were observed, especially for negative PLGA NPs that led to a higher inflammatory response, which can be correlated to a higher uptake of these NPs. Taken together, these results show that both coating of PLGA NPs and the nature of the core play a key role in cell response.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Inflammatory response; Lung cells; Nanoparticles; PLGA

Mesh:

Substances:

Year:  2013        PMID: 23747506     DOI: 10.1016/j.ijpharm.2013.05.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  19 in total

1.  Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.

Authors:  Sathish Dyawanapelly; Uday Koli; Vimisha Dharamdasani; Ratnesh Jain; Prajakta Dandekar
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

Review 2.  Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.

Authors:  Young H Lim; Kristin M Tiemann; David A Hunstad; Mahmoud Elsabahy; Karen L Wooley
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-25

3.  Polymeric nanoparticles for pulmonary protein and DNA delivery.

Authors:  Jyothi U Menon; Priya Ravikumar; Amruta Pise; Dipendra Gyawali; Connie C W Hsia; Kytai T Nguyen
Journal:  Acta Biomater       Date:  2014-02-08       Impact factor: 8.947

Review 4.  Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.

Authors:  Roshni Iyer; Connie C W Hsia; Kytai T Nguyen
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 5.  A Review of Molecular Mechanisms Involved in Toxicity of Nanoparticles.

Authors:  Javad Khalili Fard; Samira Jafari; Mohammad Ali Eghbal
Journal:  Adv Pharm Bull       Date:  2015-11-30

Review 6.  Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.

Authors:  Caleb F Anderson; Maria E Grimmett; Christopher J Domalewski; Honggang Cui
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-10

7.  Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake.

Authors:  Surya P Lamichhane; Neha Arya; Nirdesh Ojha; Esther Kohler; V Prasad Shastri
Journal:  Int J Nanomedicine       Date:  2015-01-19

8.  Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro.

Authors:  Zofi McKenzie; Michaela Kendall; Rose-Marie Mackay; Teresa D Tetley; Cliff Morgan; Mark Griffiths; Howard W Clark; Jens Madsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

9.  Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium.

Authors:  Andrew J Thorley; Pakatip Ruenraroengsak; Thomas E Potter; Teresa D Tetley
Journal:  ACS Nano       Date:  2014-11-04       Impact factor: 15.881

10.  Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: lipid nanoparticles versus polymeric nanoparticles.

Authors:  Tsong-Long Hwang; Ibrahim A Aljuffali; Chwan-Fwu Lin; Yuan-Ting Chang; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2015-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.